Wells Fargo’s Allergan plc AGN Stock Holding History

Wells Fargo’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-90,000	Closed	-$1.56M	–	6579
2017 Q1	$1.56M	Sell	90,000 -7,300	-8%	-$1.7M	﹤0.01%	3398
2016 Q4	$1.04M	Buy	+97,300	New	+$20.2M	﹤0.01%	3659
2016 Q3	–	Sell	-50,000	Closed	-$5K	–	6446
2016 Q2	$5K	Buy	+50,000	New	+$11.5M	﹤0.01%	5828
2014 Q3	–	Sell	-50,000	Closed	-$11.2M	–	6429
2014 Q2	$11.2M	Hold	50,000	–	–	﹤0.01%	1737
2014 Q1	$3.65M	Hold	50,000	–	–	﹤0.01%	2551
2013 Q4	$2.04M	Buy	+50,000	New	+$7.82M	﹤0.01%	2928

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wells Fargo's AGN Position: Q2 2020 in Review

Wells Fargo sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,419,011 shares — an estimated $251M sold.

Wells Fargo first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $665M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Wells Fargo reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Wells Fargo sold 1,419,011 Allergan plc shares in Q2 2020, an estimated $251M.
Wells Fargo first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
Wells Fargo's Allergan plc position peaked at $665M in Q3 2015.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wells Fargo's 13F filing for Q2 2020, filed 13 Aug 2020.